AstraZeneca no longer recommended as 1st or 2nd COVID-19 vaccine dose, NACI says. Panel says emerging evidence suggests mRNAs such as Pfizer or Moderna trigger better immune response, and that growing availability of mRNAs makes the change possible. https://t.co/gjCziuZV5Y